In a study of RCC, the results indicated that PD-1/LAG-3 (rather than PD-1/TIM-3 blockade) improved the immune function of stimulated RCC TILs (P ═ 0.0302, Fisher’s exact test) [85]. This evidence concerns the gene HAVCR2 and renal cell carcinoma.